They found that mRNA expression of IL-17 in tumors was associated with the depth of the tumors, lymph-vascular invasion, and lymph node involvement.39 This led the authors to suggest that IL-17 is linked to tumor progression. The gene discussed is IL17A; the disease is neoplasm.